Organization | ICOS

ICOS Report issue

Contributed to NME For profit Phase 2 Phase 3 Phase 4

Founded: Bothell WA United States (1989)

Status: Acquired by Eli Lilly (2007)

Organization Overview

First Clinical Trial

1996

Unregistered Trial 1

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2006

Timeline

NOW

Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ICOS Corporation | ICOS-Texas Biotechnology

Active Ingredients

Drugs in Phase 4 Trials (2)

sildenafil (viagra) (3 trials)

tadalafil (cialis) (22 trials)

Drugs in Phase 3 Trials (2)

rpaf-ah (1 trial)

sitaxentan (1 trial)

Drugs in Phase 2 Trials (2)

rovelizumab (LeukArrest) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Erectile Dysfunction (Phase 4)

Gastroparesis (Phase 2)

Hyperplasia (Phase 3)

Hypertension (Phase 3)

Hypertension, Pulmonary (Phase 3)

Pneumonia (Phase 2)

Prostatic Hyperplasia (Phase 3)

Sepsis (Phase 3)

Signs and Symptoms (Phase 3)

Spinal Cord Injuries (Phase 3)

Toxemia (Phase 3)

Wounds and Injuries (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 26
# of Trial APIs: 6